Physician profile
Alexey Knyazhitskiy
NPI 1942484092
$71,430.47
in general payments reported to CMS, 2019-2025
11 companies · $12K in 2025
The $12K reported for 2025 was more than what 94% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $5,116 · 2021: $7,549 · 2022: $9,586 · 2023: $19K · 2024: $17K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $45K · Food and Beverage: $2,957 · Travel and Lodging: $613 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $45,227.01 |
| Food and Beverage | $2,957.02 |
| Travel and Lodging | $612.56 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $58,289.46 | 2019-2024 | Yupelri, Yupelri |
| Viatris Specialty LLC | $12,002.47 | 2025 | Yupelri |
| Astrazeneca Pharmaceuticals Lp | $721.09 | 2019-2025 | Fasenra, Tezspire, Tudorza Pressair |
| Inspire Medical Systems, INC. | $216.43 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $49.27 | 2021 | |
| Pfizer INC. | $41.83 | 2019-2020 | |
| Amgen INC. | $34.00 | 2025 | |
| Sunovion Pharmaceuticals INC. | $23.98 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $21.84 | 2019 | |
| Paratek Pharmaceuticals, INC. | $17.86 | 2021 | |
| Astellas Pharma US INC | $12.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexey Knyazhitskiy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.